Birnam Oak Advisors, LP / CATBUSD
Birnam Oak Advisors, LP’s Astria Therapeutics Inc Position
Does Birnam Oak Advisors, LP own Astria Therapeutics Inc (CATBUSD)? Not currently — the last reported position was 689.7K shares worth $9M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$9M
Q4 2025
Shares
689.7K
% of Portfolio
+2.02%
Quarters Held
1
position exited
Position History CATBUSD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 689.7K | $9M | +2.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birnam Oak Advisors, LP’s full portfolio or all institutional holders of CATBUSD.